3T场强下WE-SHARP-DWI与SPAIR-DWI对局灶性肝脏病灶诊断效能的增强对比
前瞻性纳入158例患者(恶性67例、良性91例)及25名志愿者,在3T下比较SPAIR-DWI、WE-SHARP-DWI及校正算法WE-SHARP-DWI*对局灶性肝脏病灶的评估。WE-SHARP序列主观图像质量优于SPAIR(P<.001),信噪比分别提高2.15倍和2.93倍,ADC测量变异性更低,诊断敏感度0.95 vs 0.88、AUC 0.98 vs 0.95。
要点
- WE-SHARP-DWI及WE-SHARP-DWI*的主观图像质量各项参数均优于SPAIR-DWI(P<.001)。
- WE-SHARP-DWI信噪比提高2.15倍、WE-SHARP-DWI*提高2.93倍,对比噪声比亦明显改善。
- WE-SHARP-DWI诊断敏感度0.95、AUC 0.98,均高于SPAIR-DWI的0.88和0.95。
核心结论
- 两种WE-SHARP-DWI技术对局灶性肝脏病灶的图像质量和诊断价值均优于传统SPAIR技术,且在高b值下仍保持临床可接受的图像质量。
研究设计与样本
- 前瞻性研究,2023年10月至2024年8月纳入158例患者(恶性67例、良性91例)和25名志愿者,在3T下采集SPAIR-DWI、WE-SHARP-DWI及WE-SHARP-DWI*,b值取50、400、800、1200 s/mm²,由两名放射科医师独立评估。
关键影像表现/征象
- WE-SHARP序列的肝脏边缘锐利度、血管勾画、病灶显著性、脂肪抑制效果、伪影及整体图像质量均优于SPAIR-DWI(P<.001)。
- WE-SHARP-DWI信噪比提高2.15倍,WE-SHARP-DWI*信噪比提高2.93倍。
- WE-SHARP序列对比噪声比分别为30.75±36.83和42.43±53.23,SPAIR-DWI为13.49±14.39。
- WE-SHARP序列正常肝脏ADC标准差分别为32.80±19.13×10⁻³ mm²/s和34.39±18.22×10⁻³ mm²/s,低于SPAIR-DWI的51.48±17.89×10⁻³ mm²/s。
- 良恶性病灶间ADC差值在WE-SHARP序列分别为1179×10⁻³ mm²/s和1197×10⁻³ mm²/s,SPAIR-DWI为1009×10⁻³ mm²/s。
诊断标准与关键数值
- WE-SHARP-DWI诊断敏感度0.95,SPAIR-DWI为0.88。
- WE-SHARP-DWI的ROC曲线下面积0.98,SPAIR-DWI为0.95。
临床应用与阅片要点
- WE-SHARP-DWI及WE-SHARP-DWI*在主观图像质量和诊断效能上均优于SPAIR-DWI,可用于局灶性肝脏病灶的评估。
- WE-SHARP序列在高b值下仍保持临床可接受的图像质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study aimed to compare the diagnostic performance of 2 fat suppression techniques in diffusion-weighted imaging (DWI) for detecting and assessing focal liver lesions (FLLs): water excitation spectral heterogeneity adaptive radiofrequency pulses (WE-SHARP) and conventional spectral adiabatic inversion recovery (SPAIR).
MATERIALS AND METHODS: This prospective study enrolled eligible participants between October 2023 and August 2024. Various DWI techniques at 3T, SPAIR-DWI, WE-SHARP-DWI, and WE-SHARP-DWI with correction algorithms (WE-SHARP-DWI*), acquired at b values of 50, 400, 800, and 1200 s/mm², were used to evaluate FLLs. Two radiologists independently assessed several subjective image quality parameters: liver edge sharpness, vessel delineation, lesion conspicuity, fat suppression effectiveness, artifacts, and overall image quality. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and apparent diffusion coefficient (ADC) values were also measured. The diagnostic performance of all 3 sequences was evaluated using receiver operating characteristic (ROC) curve analysis.
RESULTS: The study included 158 patients (67 with malignant and 91 with benign lesions) and 25 volunteers. Compared with SPAIR-DWI, the subjective image quality parameters were superior for both WE-SHARP sequences (P < .001). SNR increased 2.15-fold with WE-SHARP-DWI and 2.93-fold with WE-SHARP-DWI*. CNR also improved substantially with the WE-SHARP sequences (30.75 ± 36.83 and 42.43 ± 53.23 vs. 13.49 ± 14.39). Further, WE-SHARP sequences demonstrated lower ADC measurement variability with lower standard deviations (32.80 ± 19.13 × 10⁻³ mm²/s and 34.39 ± 18.22 × 10⁻³ mm²/s vs. 51.48 ± 17.89 × 10⁻³ mm²/s) in normal liver and more pronounced ADC differences between benign and malignant lesions (1179 × 10⁻3 mm²/s and 1197 × 10⁻3 mm²/s vs. 1009 × 10⁻3 mm²/s.). The WE-SHARP-DWI techniques demonstrated improved diagnostic performance with higher sensitivity (0.95 vs. 0.88) and greater area under the ROC curve (0.98 vs. 0.95) compared with SPAIR-DWI.
CONCLUSIONS: Both WE-SHARP-DWI techniques demonstrated superior image quality and diagnostic value for assessing FLLs than the conventional SPAIR technique. These techniques retained clinically acceptable image quality even at high b values.
引用
- Liu X, Yang L, Zhang Y, et al. Enhanced diagnostic performance of WE-SHARP-DWI compared with SPAIR-DWI for focal liver lesion evaluation at 3T. Abdom Radiol (NY). 2025. PMID: 40900232. doi:10.1007/s00261-025-05189-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。